These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1386050)

  • 41. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E; Marschall HU; Winograd R; Matern S
    Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Displacing effects of chenodeoxycholic acid, ursodeoxycholic acid and sulfadimethoxine on plasma protein binding of tolbutamide.
    Goto S; Watanabe S; Maehara S; Nakata Y; Tateyama T
    J Pharmacobiodyn; 1985 Jun; 8(6):440-7. PubMed ID: 4057039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes.
    Zhang MH; Setchell KD; Zhao J; Gong JY; Lu Y; Wang JS
    World J Gastroenterol; 2019 Feb; 25(7):859-869. PubMed ID: 30809085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chenodeoxycholic and ursodeoxycholic acids alter motility and fluid transit in the canine ileum.
    Kruis W; Haddad A; Phillips SF
    Digestion; 1986; 34(3):185-95. PubMed ID: 3758514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor.
    Ellis E; Axelson M; Abrahamsson A; Eggertsen G; Thörne A; Nowak G; Ericzon BG; Björkhem I; Einarsson C
    Hepatology; 2003 Oct; 38(4):930-8. PubMed ID: 14512880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of cholestasis and bile acids on interferon-induced 2',5'-adenylate synthetase and NK cell activities.
    Podevin P; Calmus Y; Bonnefis MT; Veyrunes C; Chereau C; Poupon R
    Gastroenterology; 1995 Apr; 108(4):1192-8. PubMed ID: 7698588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical pharmacology of ursodeoxycholic acid (UDCA)].
    Kryczka W; Grieb P
    Postepy Hig Med Dosw; 1994; 48(1):53-68. PubMed ID: 8058580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cholecystokinin effect on human intestinal permeability: influence of chenodeoxycholic and ursodeoxycholic acid administration.
    Budillon G; Parrilli G; Capuano G; Mazzacca G; Menzies IS
    Digestion; 1982; 24(4):274-80. PubMed ID: 7152150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ursodeoxycholic acid attenuates colonic epithelial secretory function.
    Kelly OB; Mroz MS; Ward JB; Colliva C; Scharl M; Pellicciari R; Gilmer JF; Fallon PG; Hofmann AF; Roda A; Murray FE; Keely SJ
    J Physiol; 2013 May; 591(9):2307-18. PubMed ID: 23507881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In vitro analysis for cellular toxicity of polychlorinated biphenyls (PCBs) and 2,3,4,7,8-pentacholorodibenzofuran (PCDF) on PLC/PRF/5 cell proliferation (II)--The effects of ursodeoxycholic acid and chenodeoxycholic acid on cell toxicity].
    Matsuoka K; Nonaka S; Ohgami T; Yoshida H
    Fukuoka Igaku Zasshi; 1993 May; 84(5):222-6. PubMed ID: 8330840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.
    Iser JH; Sali A
    Drugs; 1981 Feb; 21(2):90-119. PubMed ID: 7009140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
    Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
    Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
    Nishigaki Y; Ohnishi H; Moriwaki H; Muto Y
    Dig Dis Sci; 1996 Jul; 41(7):1487-93. PubMed ID: 8689929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid.
    Silva RF; Rodrigues CM; Brites D
    J Hepatol; 2001 Mar; 34(3):402-8. PubMed ID: 11322201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
    Narisawa T; Fukaura Y; Terada K; Sekiguchi H
    J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The influence of chenodeoxycholic acid and ursodeoxycholic acid on the hepatic structure of the rat (author's transl)].
    Leuschner U; Schneider M; Korte L
    Z Gastroenterol; 1979 Apr; 17(4):244-55. PubMed ID: 433375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differing effect of chenodeoxycholic acid and ursodeoxycholic acid on bile acids in rat colonic wall and contents.
    Kurtz WJ; Guldutuna S; Leuschner U
    Tokai J Exp Clin Med; 1988 Jun; 13(2):91-7. PubMed ID: 3250006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes.
    Bouscarel B; Fromm H; Ceryak S; Cassidy MM
    Biochem J; 1991 Dec; 280 ( Pt 3)(Pt 3):589-98. PubMed ID: 1764022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations.
    Fricker G; Fahr A; Beglinger C; Kissel T; Reiter G; Drewe J
    Br J Pharmacol; 1996 Jan; 117(1):217-23. PubMed ID: 8825366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.